EPIDEMIOLOGICAL ASPECTS OF BREAST CANCER. LITERATURE REVIEW.
Relevance. Breast cancer in young women is rare, affecting only 4-6% of women under the age of 40. Despite this, breast cancer remains the most common malignant tumor among young patients. Recently, there has been a significant increase in the frequency of this disease among premenopausal individuals. Breast cancer in young women requires special attention due to its specific morphological and prognostic characteristics and unique aspects, including fertility preservation and psychosocial problems (for example, its impact on family life and career). In young women, tumors with a higher frequency of negative clinical and pathological signs are more common (higher histological assessment, greater positivity of lymph nodes, lower positivity of estrogen receptors, higher rates of overexpression. In addition, they are usually diagnosed at later stages of the disease. This, in turn, indicates a less favorable prognosis compared to older women. Young women, as a rule, are treated in the same way as older patients. Surgical treatment includes mastectomy or breast preservation surgery followed by radiation therapy (in young women, the frequency of local relapses is higher than in older women, especially after breast preservation therapy). Although the basics of chemotherapy are the same for patients of all ages. It is important to consider options for maintaining fertility before starting systemic treatment. Patients should have access to genetic testing, as its results may affect the choice of therapy. Young women and their families should receive adequate psychological support and counseling. Aim. To analyze the literature data on the epidemiology of breast cancer. Search strategy. The study examined full-text publications in English and Russian, which are devoted to the epidemiological aspects of breast cancer. In the process of literature search, the following search engines were used: Pubmed, Web of science, Cyberleninka, Google Scholar by keywords. The time period was designated 2011-2021. The criteria for including publications in the review were as follows: publications in Russian and English that are in open full-text access and contain statistically confirmed conclusions. Summary reports, newspaper articles and personal messages were excluded from the review. 1516 publications have been identified on this topic. Of these, 39 publications corresponded to the purpose of our study. Results and conclusions.The analysis of morbidity and mortality rates from breast cancer over the past 10 years clearly indicates that the process of neo-oncogenesis in the world continues and tends to intensify. At the same time, the situation in the regions for breast cancer is seriously deteriorating, and this requires the oncological service to concentrate its efforts on finding ways to detect breast cancer early, diagnose it in a timely manner, and develop new more effective methods of prevention and treatment of this disease.
Yerzat N. Aimukhambetov1, https://orcid.org/0000-0002-9597-470X Zaituna A. Khismetova1, https://orcid.org/0000-0001-5937-3045 Umutzhan S. Samarova1, https://orcid.org/0000-0003-3320-7115 Maxut T. Senbekov2, https://orcid.org/0000-0003-3954-1317 1 NCJSC «Semey Medical University», Semey city, Republic of Kazakhstan; 2 Kazakhstan’s Medical University “Kazakhstan School of Public Health”, Almaty c., Republic of Kazakhstan.
1. Bethea T.N. et al. A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium // Breast Cancer Research. 2015. №1 (17). С.89-97 2. Bhoo-Pathy B.H. Ethnic differences in survival after breast cancer in South East Asia // PloS one. 2012. №2 (7). 3. Bozovic-Spasojevic I. et al. Chemoprevention for breast cancer // Cancer Treatment Reviews. 2012. №5 (38). C. 329–339. 4. Brewer H. R. et al. Family history and risk of breast cancer: an analysis accounting for family structure // Breast Cancer Research and Treatment. 2017. №1 (165). C. 193–200. 5. Catsburg C., Miller A.B., Rohan T.E. Active cigarette smoking and risk of breast cancer // International Journal of Cancer. 2015. №9 (136). C. 2204–2209. 6. Chlebowski Rowan T. Nutrition and physical activity influence on breast cancer incidence and outcome // Breast (Edinburgh, Scotland). 2013. №S2 (22 Suppl 2), С. 184-192 7. Choi Y. et al. Age-period-cohort analysis of female breast cancer mortality in Korea // Cancer Research and Treatment. 2016. №1 (48). C. 11–19. 8. Endogenous Hormones and Breast Cancer Collaborative Group Sex hormones and breast cancer risk in premenopausal women: collaborative reanalysis of seven prospective studies // Lancet Oncology. 2013. № 10 (14). C. 1009–1019. 9. Fahlén M. et al. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial // European Journal of Cancer. 2013. № 1 (49). C. 52–59. 10. Ferlay J. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 // International journal of cancer. 2010. № 12 (127). C. 2893–2917. 11. Ferlay J. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 // International journal of cancer. 2015. № 5 (136). C. E359–E386. 12. Fitzmaurice C. The Global Burden of Cancer 2013 // JAMA oncology. 2015. № 4 (1). C. 505–527. 13. Gaudet M.M. et al. Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies // International Journal of Epidemiology. 2017. № 3 (46). C. 881–893. 14. Ghiasvand R. Higher incidence of premenopausal breast cancer in less developed countries; myth or truth? // BMC cancer. 2014. № 1 (14). C. 1–8. 15. Ghoncheh M., Mohammadian-Hafshejani A.S. Incidence and Mortality of Breast Cancer and their Relationship to Development in Asia // Asian Pacific journal of cancer prevention . 2015. № 14 (16). C. 6081–6087. 16. Guo P. Trends in cancer mortality in China: an update // Annals of oncology : official journal of the European Society for Medical Oncology. 2012. № 10 (23). C. 2755–2762. 17. Jack R.H. Breast cancer and age in Black and White women in South East England // International journal of cancer. 2012. № 5 (130). C. 1227–1229. 18. Jemal A. B. Global cancer statistics // CA: a cancer journal for clinicians. 2011. № 2 (61). C. 69–90. 19. Jordan I. et al. Breast cancer risk among women with long-standing lactation and reproductive parameters at low risk level: A case-control study in Northern Tanzania // Breast Cancer Research and Treatment. 2013. № 1 (142). C. 133–141. 20. Keramatinia A.., Mousavi-Jarrahi S.H., Hiteh M.M. Trends in incidence of breast cancer among women under 40 in Asia // Asian Pacific journal of cancer prevention : APJCP. 2014. № 3 (15). C. 1387–1390. 21. Kispert S., McHowat J. Recent insights into cigarette smoking as a lifestyle risk factor for breast cancer // Breast Cancer: Targets and Therapy. 2017. (9). C. 127–132. 22. Lertkhachonsuk A. Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013 // The Lancet. Oncology. 2013. № 12 (14). 23. Liu J.Y., Chen T.J., Hwang S.J. The risk of breast cancer in women using menopausal hormone replacement therapy in Taiwan // International Journal of Environmental Research and Public Health. 2016. № 5 (13). 24. Luengo-Fernandez R. Economic burden of cancer across the European Union: a population-based cost analysis // The Lancet. Oncology. 2013. №12 (14). C. 1165–1174. 25. Makarem N. et al. Dietary fat in breast cancer survival // Annual Review of Nutrition. 2013. № 1 (33). C. 319–348. 26. Marmot M.G. et al. The benefits and harms of breast cancer screening: An independent review // British Journal of Cancer. 2013. № 11 (108). C. 2205–2240. 27. McKenzie F. et al. Cigarette Smoking and Risk of Breast Cancer in a New Zealand Multi-Ethnic Case-Control Study // PLoS ONE. 2013. № 4 (8). 28. Morrow M., Waters J., Morris E. MRI for breast cancer screening, diagnosis, and treatment // The Lancet. 2011. № 9805 (378). C. 1804–1811. 29. Radecka B., Litwiniuk M. Breast cancer in young women // Ginekologia polska. 2016. № 9 (87). C. 659–663. 30. Rahimzadeh M. Estimation of the cure rate in Iranian breast cancer patients // Asian Pacific journal of cancer prevention : APJCP. 2014. № 12 (15). C. 4839–4842. 31. Razi S. Changing Trends of Types of Skin Cancer in Iran // Asian Pacific journal of cancer prevention : APJCP. 2015. № 12 (16). C. 4955–4958. 32. Santis C.E. International Variation in Female Breast Cancer Incidence and Mortality Rates // Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2015. № 10 (24). C. 1495–1506. 33. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2017 // CA: A Cancer Journal for Clinicians. 2017. № 1 (67). C. 7–30. 34. Torre L.A. Global cancer statistics, 2012 // CA: a cancer journal for clinicians. 2015. № 2 (65). C. 87–108. 35. Troisi R., Altantsetseg D. Breast cancer incidence in Mongolia // Cancer causes & control : CCC. 2012. № 7 (23). C. 1047–1053. 36. Vahabi M. Breast cancer screening disparities among urban immigrants: a population-based study in Ontario, Canada // BMC public health. 2015. № 1 (15). 37. Valastyan S., Weinberg R. A. Tumor Metastasis: Molecular Insights and Evolving Paradigms The Invasion-Metastasis Cascade // Cell. 2011. № 2 (147). C. 275–292. 38. Veisy A., Viga M. The role of oral contraceptive pills on increased risk of breast cancer in North West of Iran // Clinical Sciences Research and Reports. 2018. № 2 (1). C. 294–301. 39. Zahedi A. Incidence, Trends and Epidemiology of Cancers in North West of Iran // Asian Pacific journal of cancer prevention : APJCP. 2015. № 16 (16). C. 7189–7193.
Number of Views: 158

Key words:

Category of articles: Reviews

Bibliography link

Aimukhambetov Ye.N., Khismetova Z.A., Samarova U.S., Senbekov M.T. Epidemiological aspects of breast cancer. Literature review // Nauka i Zdravookhranenie [Science & Healthcare]. 2021, (Vol.23) 6, pp. 198-204. doi:10.34689/SH.2021.23.6.021

Авторизируйтесь для отправки комментариев